WCN26-3866 Prescribing patterns and potential medication-associated CKD progression in Japan: analysis of a large claims database

Read full text Summarise with VIRAT
Authors: Kenji Momo, Mana Okumo, Haruki Funakoshi, Jan Dominik Kampmann, Abdul Rashid Qureshi, Bengt Lindholm
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Patients with chronic kidney disease (CKD) need to avoid drugs with potential renal toxicity and CKD-stage contraindications. However, certain potentially harmful drugs such as benzodiazepines, opioids, antipsychotics, mood stabilizers may evade such classifications. Real-world evidence from Japan on prescribing patterns of such potentially harmful drugs and their association with kidney function decline remains limited.

Fields of Study & Subjects

Pharmaceutical Practices and Patient Outcomes Chronic Kidney Disease and Diabetes Acute Kidney Injury Research

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104763–104763
Publication date
25 March 2026
Language
EN